USC Norris Comprehensive Cancer Center — Los Angeles, California

Public research footprint of USC Norris Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

1,213

Registered studies

383

Active

174

Recruiting now

536

Completed

259

Stopped or withdrawn

Most-studied conditions

Myelodysplastic Syndrome With Excess Blasts · Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Metastatic Non-Cutaneous Melanoma · Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05600894 — Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at USC Norris Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.